The COVID-19 pandemic has changed the perspective on public health. As the world progresses through the situation and a possible subsequent mental health pandemic, the future of public health will be precise, predictive, participatory, and personalized. These concepts will help the health sector navigate the changing public health principles.
Public health has become much more than just focusing on lifestyle paradigms and health promotion to prevent diseases. It now encompasses a holistic view beyond clinical health and reactive care. It now incorporates economic, geographic, political, social, and environmental determinants to improve the treatment outcomes while reducing costs.
Precision medicine is an emerging approach to disease treatment and prevention. It considers individual gene variability, lifestyles, and the environment. These factors allow doctors to be more accurate in their treatment and prevention strategies for particular diseases. It sharply contrasts with the one-size-fits-all approach, in which treatment and prevention strategies apply across the board.
Precision medicine is even more crucial in the future of public health. The Assistant Professor of Genomic Medicine at Geisinger Health Systems, Nephi Walton, notes that the institution is already embracing genomic medicine to change people’s lives. With over 6,000 known genetic diseases, hospitals need to undertake heavy tech lifting to improve scientific wellness. It is the only way to get so much information.
At the Institute of Human Data Science, they have already made enormous strides to understand biology and how it affects human health, related to disease, and defines wellness. The promise of precision medicine will become a discipline and not a disease-specific approach.
Precision medicine is also personalized medicine and is a promising approach to tackling diseases that have in the past eluded effective cures. Cancer and rare genetic conditions, for example, take a toll on society. Many are preventable through lifestyle changes like weight loss, reducing alcohol intake, and quitting tobacco. On the other hand, some result from predisposition to hereditary diseases along racial, ethnic, and familial lines.
The MD and Vice President of Quantitative Medicine, Peter Bergethon, says that the next phase in public health is not about drugs but engaging patients in their treatment plans. Technologies like AI and wearables exist, and their availability is on a wide scale. It calls for doctors to take that information to patients more precisely, to help them consume it in ways they consume data.
Healthcare in the 21st century will continue to focus on improving wellness for the individual. The approach will entail creating preventative, participatory, and personalized medicine to reverse the rising cost trends.
Experts explain that using Alzheimer’s as an example, computer-aided diagnostics, and patient data clouds will enable clinicians and researchers to identify the earliest sign of cognitive decline. Scientists will be able to divide the disease into subtypes. Using individuals with a high genetic risk, they’ll be able to track mental progress.
At Tesis Biosciences, patient care is at the center of what we do every day. With the new trends for patient care in the coming year, we strive to bridge the gap between the patient and the healthcare provider in laboratory testing. For more information on the future of precision medicine and personalized healthcare, visit our blog.